Search

Understanding how a protein affects the growth and development of lymphoma cells in order to build the foundations for safer and more effective treatments.

Investigating whether giving a medicine before doxorubicin cancer treatment could prevent heart damage.

Understanding how proteins act inside acute myeloid leukaemia cells, to find new drug targets.

Creating antibodies in the lab to treat diffuse midline gliomas and testing their effectiveness.

Helping children in sub-Saharan Africa with endemic Burkitt Lymphoma get diagnosed earlier.

Ependymoma comes back after treatment around half of the time, because some cancer cells are still alive. If doctors could identify these cells and diagnose relapsed ependymoma sooner, children could start treatment earlier.

Looking at how nanoparticles could improve drug delivery and reduce toxicity for young cancer patients.

Using models to find out how high risk leukaemia cells grow and become resistant to treatment.

Stopping protein activity to stop anaplastic large cell lymphomas from growing.

Using anti-depressants to prevent the body's immune system from fighting immunotherapy treatments.